Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 24c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.46), $0.24 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $142 million versus the consensus estimate of $125.21 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
• Landstar System (LSTR) Tops Q1 EPS by 4c
• Goosehead Insurance Inc. (GSHD) Tops Q1 EPS by 7c, Revenue Misses; Offers FY24 Revenue Guidance